
Sinterx Pharma Private Limited
Manufactures and exports pharmaceuticals and bio-analytical services.
Manufactures and exports pharmaceuticals and bio-analytical services.
Sinterx Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2021 (Three years and six months 9 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹4.05 Cr.
Golla Padmavathi, Deepika Punnapu, and Sruthi Medapati serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
-
U24299TG2021PTC154397
154397
Private Limited Indian Non-Government Company
26 Aug 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Golla Padmavathi ![]() | Director | 01-Dec-2021 | Current |
Deepika Punnapu ![]() | Director | 26-Aug-2022 | Current |
Sruthi Medapati ![]() | Director | 26-Aug-2021 | Current |
Sinterx Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 172.73% increase. The company also saw a substantial improvement in profitability, with a 226.91% increase in profit. The company's net worth Soared by an impressive increase of 266.4%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Sinterx Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Golla Padmavathi and Sruthi Medapati are mutual person
₹40.50 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
23 Aug 2024 | Axis Bank Limited | ₹4.05 Cr | Open |
Sinterx Pharma has a workforce of 12 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sinterx Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sinterx Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sinterx Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Axis Bank Limited amounted to Rs. 40.50 M with Charge ID 100979731 was registered on 23 Aug 2024.
Sinterx Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Deepika Punnapu was appointed as a Director was appointed as a Director on 26 Aug 2022 & has been associated with this company since 2 years 6 months .
Golla Padmavathi was appointed as a Director was appointed as a Director on 01 Dec 2021 & has been associated with this company since 3 years 3 months .
Sruthi Medapati was appointed as a Director was appointed as a Director on 26 Aug 2021 & has been associated with this company since 3 years 6 months .
Sinterx Pharma Private Limited was incorporated on 26 Aug 2021.
The authorized share capital of Sinterx Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.75 M.
Currently 3 directors are associated with Sinterx Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sinterx Pharma Private Limited is Flat No 201 Sai Acrade Plot No.18 Survey No.66/2, Raidurgam India, Seri Lingampally, Telangana, 500032.
The corporate identification number (CIN) of Sinterx Pharma Private Limited is U24299TG2021PTC154397 and the company number is 154397 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Sinterx Pharma Private Limited has risen by 172.73%.
As Per 2023 financial reports, 12 employees are currently employed by Sinterx Pharma Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Sinterx Pharma Private Limited has experienced an upsurge of 266.40%.
As per the financial statements for fiscal Year 2023, The total open charges for Sinterx Pharma Private Limited amount to ₹ 4.05 Cr.
The most recent Balance Sheet for Sinterx Pharma Private Limited was filed with the ROC on 31 Mar 2024.
SK
LA